Sands Capital Life Sciences Pulse Fund, L.P. — Form D
Sands Capital Life Sciences Pulse Fund, L.P. of ARLINGTON, VA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-07-03. $51.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-07-03
- Form: D
- Accession: 0001779203-19-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $51.4M
- Minimum investment: $100K
- Investors: 15
- Date of first sale: 2019-06-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-343518
Issuer
- Name: Sands Capital Life Sciences Pulse Fund, L.P.
- CIK: 0001779203
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: C/O SANDS CAPITAL VENTURES, LLC, ARLINGTON, VA, 22209
- Phone: 703-562-4000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Erin Soule | Executive Officer | Arlington, VA |
| Jonathan Goodman | Executive Officer | Arlington, VA |
| STEPHEN ZACHARY | Executive Officer | ARLINGTON, VA |
| JOB TAYLOR | Executive Officer | ARLINGTON, VA |
Other filings by this issuer (1)
More